ReviewOncoTargets and therapy2023

Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin.

Noa E Wijnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.